These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 4967928)

  • 1. [Prevention of hemolytic disease of the newborn with anti-D administration to the mother. 2].
    Dtsch Med Wochenschr; 1968 Jun; 93(24):1176-9. PubMed ID: 4967928
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prevention of RH-erythroblastosis by anti-D-application to the mother].
    Stahl M; Althoff W; Schellong G
    Monatsschr Kinderheilkd (1902); 1968 Jun; 116(6):236-8. PubMed ID: 4975896
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunosuppressive mechanism and effect of immunoglobulins Anti D and Anti DK (IgG) in the prevention of hemolytic disease of the newborn caused by Rh incompatibility].
    Skrzypulec ZA
    Zentralbl Gynakol; 1973 Mar; 95(12):402-10. PubMed ID: 4634158
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevention of haemolytic disease of the newborn by anti-D serum given to the mother.
    Schneider J; Preisler O; Haering M; Krüger H; Welsch H; Althoff W; Stahl M; Schellong G
    Ger Med Mon; 1967 Dec; 12(12):570-1. PubMed ID: 4967929
    [No Abstract]   [Full Text] [Related]  

  • 5. Prevention of Rho hemolytic disease of the newborn: the rosette method--a rapid, sensitive screening test.
    Taswell HF; Reisner RK
    Mayo Clin Proc; 1983 May; 58(5):342-3. PubMed ID: 6405102
    [No Abstract]   [Full Text] [Related]  

  • 6. [Prevention of anti Rh immunization].
    Pinon F
    Sem Hop; 1969 Sep; 45(37):2328-33. PubMed ID: 4187740
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis, prevention, and therapy in hemolytic disease of the newborn.
    Polesky HF
    Clin Lab Med; 1982 Mar; 2(1):107-22. PubMed ID: 6821161
    [No Abstract]   [Full Text] [Related]  

  • 8. [Actual possibilities of prevention of serologic incompatibility].
    Breborowicz H; Gerwelowa H; Krawczyńska Z; Baraniecka K; Gruszczyńska J; Karowa L
    Pol Tyg Lek; 1968 Sep; 23(35):1305-7. PubMed ID: 4972438
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of systematic detection and identification of irregular antibodies in pregnant women where anti D+ jka immunization is recognized tardily].
    Baumes RM; Muller F; Aneflous B; Bouakline D
    Voen Med Zh; 1970 Aug; 8():458-64. PubMed ID: 4995496
    [No Abstract]   [Full Text] [Related]  

  • 10. [Importance of systematic detection and identification of irregular antibodies in pregnant women where anti D+ jka immunization is recognized tardily].
    Baumes RM; Muller F; Aneflous B; Bouakline D
    Maroc Med; 1970 Jul; 537():458-64. PubMed ID: 4993873
    [No Abstract]   [Full Text] [Related]  

  • 11. Total prevention of Rh hemolytic disease: possible or impossible?
    Bowman JM
    Am J Pediatr Hematol Oncol; 1981; 3(3):323-30. PubMed ID: 6169290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary experiences with the prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993890
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of Rh sensitization from fetomaternal microtransfusions.
    Schneider J; Preisler O
    Obstet Gynecol; 1966 Nov; 28(5):615-21. PubMed ID: 4958982
    [No Abstract]   [Full Text] [Related]  

  • 14. [Preliminary experiences with ther prevention of Rh sensitization].
    Aeppli H; Nwebube G
    Gynaecologia; 1969; 168(6):481-3. PubMed ID: 4993202
    [No Abstract]   [Full Text] [Related]  

  • 15. Prophylaxis of maternal RH-sensitization by means of anti-D immunoglobulin.
    Petrov-Maslakov MA; Vasilyeva ZF; Matveyeva OF; Balasanyan IG; Sorina LI; Prigarnova TK
    Arch Immunol Ther Exp (Warsz); 1971; 19(3):343-8. PubMed ID: 4999474
    [No Abstract]   [Full Text] [Related]  

  • 16. Mothers at risk of alloimmunization to the Rh (D) antigen and availability of gamma-globulin at the Mexican Institute of Social Security.
    Zavala C; Salamanca F
    Arch Med Res; 1996; 27(3):373-6. PubMed ID: 8854398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The fight against hemolytic disease of the newborn-- an example of interdisciplinary cooperation].
    Müller S; Roewer J; During R; Hille M; Plath C
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(5):720-4. PubMed ID: 2435640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Passive antibody transfer into the parturient's blood after anti-D immunoglobulin administration for prevention of Rh sensitization].
    Merlak I; Mikulandra F; Kapitanović Z
    Lijec Vjesn; 1973 Jan; 95(1):11-3. PubMed ID: 4632047
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prophylaxis of hemolytic disease of newborn].
    Kietlińska-Kmiolek Z
    Wiad Lek; 1971 Apr; 24(8):755-60. PubMed ID: 4996047
    [No Abstract]   [Full Text] [Related]  

  • 20. [Obtaining blood group test serums and initial plasma for the preparation of anti D-immunologlobulin for prevention of hemolytic disease of newborn by artificial immunization].
    Pilgrim G; Wicht U
    Z Gesamte Inn Med; 1971 Jan; 26(1):26-30. PubMed ID: 4997869
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.